Acadia Healthcare (NASDAQ:ACHC) Raised to “Hold” at StockNews.com

Acadia Healthcare (NASDAQ:ACHC) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Thursday.

Other equities analysts have also recently issued reports about the company. KeyCorp initiated coverage on Acadia Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Cantor Fitzgerald reiterated a “neutral” rating and issued a $52.00 price target on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Royal Bank of Canada lowered their target price on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research report on Monday, November 18th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price target for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Finally, Barclays cut their price objective on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research report on Friday, November 22nd. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $75.44.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $37.90 on Thursday. The company has a 50 day moving average of $44.14 and a 200 day moving average of $61.09. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a twelve month low of $36.50 and a twelve month high of $87.77. The firm has a market cap of $3.52 billion, a P/E ratio of 12.43, a PEG ratio of 1.77 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.91 earnings per share. As a group, research analysts expect that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Trading of Acadia Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in ACHC. GAMMA Investing LLC increased its position in shares of Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after purchasing an additional 241 shares in the last quarter. Blue Trust Inc. lifted its stake in shares of Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after purchasing an additional 248 shares during the period. Commonwealth Equity Services LLC raised its position in shares of Acadia Healthcare by 3.5% in the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after acquiring an additional 257 shares during the period. Atria Investments Inc raised its holdings in Acadia Healthcare by 4.7% in the 3rd quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock worth $434,000 after purchasing an additional 308 shares during the period. Finally, KBC Group NV lifted its position in shares of Acadia Healthcare by 14.4% during the 3rd quarter. KBC Group NV now owns 2,688 shares of the company’s stock valued at $170,000 after buying an additional 338 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.